StockNews.AI
ABL
StockNews.AI
74 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

1. Pomerantz LLP is investigating Abacus for potential securities fraud. 2. Morpheus Research claims Abacus uses misleading revenue reporting methods. 3. Abacus's stock dropped 21.47% to $6.00 after the report's release. 4. The report raises concerns over valuation methodology and life expectancy estimates. 5. Historical red flags identified regarding Abacus's co-founders are worrisome.

3m saved
Insight
Article

FAQ

Why Very Bearish?

Abacus's significant stock decline reflects serious investor concerns about credibility and risk, historically linked to stock instability and losses.

How important is it?

The investigation raises substantial concerns affecting investor trust and stock valuation, directly impacting ABL's future performance.

Why Short Term?

Immediate effects are more severe due to ongoing investigations and market reactions to fraud allegations.

Related Companies

SPACMORPH
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, 2025, Morpheus Research a report entitled “Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue By Systematically Underestimating When People Will Die.” The report alleges that Abacus incorporated a change in its portfolio valuation methodology to make Abacus appear more profitable that it actually is. The report also alleges that Abacus uses questionable methodologies for calculating life expectancy estimates and identified historical “red flags” associated with Abacus’s co-founders.  On this news, Abacus’s stock price fell $1.64 per share, or 21.47%, to close at $6.00 per share on June 5, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Related News